Zivo Bioscience, Inc.
ZIVO· OTC
Filed May 15, 2012 · 10-Q · 45 days after period end · 0001078782-12-001380
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $0.00 | $36.33K |
| Net Income | -$1.06M | -$467.28K |
| EPS Diluted | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 15, 2012 · 45 d after period end